Teva Set to Resume Deals After Investors Reward Rivals

... what these deals are doing to the share prices" of other acquirers, said Kevin Kedra, an analyst for Gabelli & Co. in Rye, New York. "Teva has a healthy business, but in this environment if you're not doing deals, you're probably not taking ...

http://ift.tt/1AN9Fy0